Article 06 Nov 2025 FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development United States Healthcare
Article 18 Aug 2025 HHS Pilot Program To Evaluate 340B Drug Pricing Program Rebate Models United States Healthcare